BiomX, Inc.
(NYSE Amex Equities : PHGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. 3.04%92.771.9%$1227.50m
JNJJohnson & Johnson 1.11%148.600.7%$1059.48m
BMYBristol-Myers Squibb Co. -0.15%59.721.0%$1024.94m
PFEPfizer Inc. -0.16%38.120.9%$854.75m
MRKMerck & Co., Inc. 2.10%80.700.7%$839.97m
LLYEli Lilly & Co. 1.71%153.221.1%$505.05m
AZNAstraZeneca Plc 2.04%54.591.2%$279.84m
NVSNovartis AG 1.39%87.480.2%$155.07m
GSKGlaxoSmithKline Plc 0.96%41.940.2%$138.99m
NVONovo Nordisk A/S 1.52%65.950.1%$91.79m
SNYSanofi 0.88%49.110.2%$75.33m
RGENRepligen Corp. 1.36%130.977.1%$69.36m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 8.29%62.590.0%$47.83m
TPTXTurning Point Therapeutics, Inc. 0.99%69.250.0%$40.47m
ARCTArcturus Therapeutics Holdings, Inc. 5.99%38.940.0%$37.16m

Company Profile

BiomX Ltd engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.